Traders are rotating out of Shiba Inu as speculative chatter intensifies around Lightchain AI, driving its presale to new ...

Polygon is making waves with its latest technical announcements, capturing attention through planned upgrades and ecosystem ...

Biogen's early-stage spinal muscular atrophy drug salanersen showed safety, motor improvements and 70% reduction in ...

Blood levels of a protein called neurofilament light chain rise significantly in MS patients up to a year before they have a ...

Biogen shared Phase I trial results, highlighting the potential benefits of the SMA treatment while promoting its once-yearly ...

As Chainlink hovers near its local top and eyes a potential correction, Lightchain AI is crossing into speculator watchlists ...

Dogecoin continues to pull headlines with its meme-driven hype and community enthusiasm, but a different kind of attention is ...

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that its partner, Biogen, shared positive topline results from the ...

Biogen has pointed to an early readout from a small phase 1 trial as evidence that its antisense oligonucleotide salanersen ...

Analysts spotlight 5 explosive crypto presales for 2025, with MAGACOIN FINANCE drawing major investor attention ahead of its ...

In this exclusive MedPage Today video, investigator Shahzad Raza, MD, of the Cleveland Clinic Cancer Institute, explains why ...